Which has higher valuation & earnings, ABT or DXCM?

Abbott Laboratories has higher revenue and earnings than DexCom. DexCom is trading at a lower price-to-earnings ratio than Abbott Laboratories, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Abbott Laboratories $44.33B 4.47 $6.52B $3.09 37.06 DexCom $4.66B 7.28 $836.30M $2.53 35.53

Does the media prefer ABT or DXCM?

In the previous week, Abbott Laboratories had 26 more articles in the media than DexCom. MarketBeat recorded 43 mentions for Abbott Laboratories and 17 mentions for DexCom. DexCom's average media sentiment score of 1.51 beat Abbott Laboratories' score of 1.40 indicating that DexCom is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Abbott Laboratories 36 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive DexCom 15 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media refer more to ISRG or ABT?

In the previous week, Abbott Laboratories had 22 more articles in the media than Intuitive Surgical. MarketBeat recorded 43 mentions for Abbott Laboratories and 21 mentions for Intuitive Surgical. Abbott Laboratories' average media sentiment score of 1.40 beat Intuitive Surgical's score of 0.72 indicating that Abbott Laboratories is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Intuitive Surgical 11 Very Positive mention(s) 3 Positive mention(s) 1 Neutral mention(s) 4 Negative mention(s) 0 Very Negative mention(s) Positive Abbott Laboratories 36 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor TSLA or ABT?

In the previous week, Tesla had 171 more articles in the media than Abbott Laboratories. MarketBeat recorded 214 mentions for Tesla and 43 mentions for Abbott Laboratories. Abbott Laboratories' average media sentiment score of 1.40 beat Tesla's score of 0.53 indicating that Abbott Laboratories is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tesla 89 Very Positive mention(s) 36 Positive mention(s) 49 Neutral mention(s) 28 Negative mention(s) 11 Very Negative mention(s) Positive Abbott Laboratories 36 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor ABBV or ABT?

In the previous week, AbbVie had 6 more articles in the media than Abbott Laboratories. MarketBeat recorded 49 mentions for AbbVie and 43 mentions for Abbott Laboratories. Abbott Laboratories' average media sentiment score of 1.40 beat AbbVie's score of 1.13 indicating that Abbott Laboratories is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AbbVie 34 Very Positive mention(s) 5 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Abbott Laboratories 36 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer BSX or ABT?

In the previous week, Abbott Laboratories had 2 more articles in the media than Boston Scientific. MarketBeat recorded 43 mentions for Abbott Laboratories and 41 mentions for Boston Scientific. Boston Scientific's average media sentiment score of 1.44 beat Abbott Laboratories' score of 1.40 indicating that Boston Scientific is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Boston Scientific 36 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Abbott Laboratories 36 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Abbott Laboratories (ABT) Competitors

$114.76 +0.34 (+0.29%)

As of 10:22 AM Eastern

Compare

ABT vs. DXCM, ISRG, TSLA, ABBV, and BSX

Should you buy Abbott Laboratories stock or one of its competitors? Abbott Laboratories's main competitors and comparable companies include DexCom (DXCM), Intuitive Surgical (ISRG), Tesla (TSLA), AbbVie (ABBV), and Boston Scientific (BSX). Companies are selected based on similarities in market, industry, and size.

How does Abbott Laboratories compare to DexCom?

Abbott Laboratories (NYSE:ABT) and DexCom (NASDAQ:DXCM) are both large-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, dividends, valuation, earnings, analyst recommendations, media sentiment, risk and institutional ownership.

Abbott Laboratories has higher revenue and earnings than DexCom. DexCom is trading at a lower price-to-earnings ratio than Abbott Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Abbott Laboratories	$44.33B	4.47	$6.52B	$3.09	37.06
DexCom	$4.66B	7.28	$836.30M	$2.53	35.53

DexCom has a net margin of 20.12% compared to Abbott Laboratories' net margin of 11.65%. DexCom's return on equity of 35.94% beat Abbott Laboratories' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Abbott Laboratories	11.65%	17.69%	9.44%
DexCom	20.12%	35.94%	14.75%

Abbott Laboratories presently has a consensus price target of $118.67, indicating a potential upside of 3.64%. DexCom has a consensus price target of $88.71, indicating a potential downside of 1.30%. Given Abbott Laboratories' stronger consensus rating and higher probable upside, analysts plainly believe Abbott Laboratories is more favorable than DexCom.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Abbott Laboratories	0 Sell rating(s)	4 Hold rating(s)	20 Buy rating(s)	3 Strong Buy rating(s)	2.96
DexCom	1 Sell rating(s)	3 Hold rating(s)	21 Buy rating(s)	2 Strong Buy rating(s)	2.89

75.2% of Abbott Laboratories shares are owned by institutional investors. Comparatively, 97.8% of DexCom shares are owned by institutional investors. 0.5% of Abbott Laboratories shares are owned by insiders. Comparatively, 0.3% of DexCom shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Abbott Laboratories has a beta of 0.59, meaning that its stock price is 41% less volatile than the broader market. Comparatively, DexCom has a beta of 1.41, meaning that its stock price is 41% more volatile than the broader market.

In the previous week, Abbott Laboratories had 26 more articles in the media than DexCom. MarketBeat recorded 43 mentions for Abbott Laboratories and 17 mentions for DexCom. DexCom's average media sentiment score of 1.51 beat Abbott Laboratories' score of 1.40 indicating that DexCom is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Abbott Laboratories	36 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
DexCom	15 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

Abbott Laboratories beats DexCom on 9 of the 17 factors compared between the two stocks.

How does Abbott Laboratories compare to Intuitive Surgical?

Intuitive Surgical (NASDAQ:ISRG) and Abbott Laboratories (NYSE:ABT) are both large-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, profitability, institutional ownership, media sentiment, dividends, earnings and analyst recommendations.

Intuitive Surgical has a beta of 1.46, meaning that its share price is 46% more volatile than the broader market. Comparatively, Abbott Laboratories has a beta of 0.59, meaning that its share price is 41% less volatile than the broader market.

Intuitive Surgical presently has a consensus price target of $508.68, suggesting a potential upside of 27.90%. Abbott Laboratories has a consensus price target of $118.67, suggesting a potential upside of 3.64%. Given Intuitive Surgical's higher possible upside, equities analysts plainly believe Intuitive Surgical is more favorable than Abbott Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Intuitive Surgical	1 Sell rating(s)	8 Hold rating(s)	22 Buy rating(s)	0 Strong Buy rating(s)	2.68
Abbott Laboratories	0 Sell rating(s)	4 Hold rating(s)	20 Buy rating(s)	3 Strong Buy rating(s)	2.96

Intuitive Surgical has a net margin of 28.45% compared to Abbott Laboratories' net margin of 11.65%. Abbott Laboratories' return on equity of 17.69% beat Intuitive Surgical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Intuitive Surgical	28.45%	16.91%	14.83%
Abbott Laboratories	11.65%	17.69%	9.44%

Abbott Laboratories has higher revenue and earnings than Intuitive Surgical. Abbott Laboratories is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Intuitive Surgical	$10.06B	13.96	$2.86B	$8.73	45.56
Abbott Laboratories	$44.33B	4.47	$6.52B	$3.09	37.06

In the previous week, Abbott Laboratories had 22 more articles in the media than Intuitive Surgical. MarketBeat recorded 43 mentions for Abbott Laboratories and 21 mentions for Intuitive Surgical. Abbott Laboratories' average media sentiment score of 1.40 beat Intuitive Surgical's score of 0.72 indicating that Abbott Laboratories is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Intuitive Surgical	11 Very Positive mention(s)	3 Positive mention(s)	1 Neutral mention(s)	4 Negative mention(s)	0 Very Negative mention(s)	Positive
Abbott Laboratories	36 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

83.6% of Intuitive Surgical shares are owned by institutional investors. Comparatively, 75.2% of Abbott Laboratories shares are owned by institutional investors. 0.6% of Intuitive Surgical shares are owned by insiders. Comparatively, 0.5% of Abbott Laboratories shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Intuitive Surgical beats Abbott Laboratories on 10 of the 17 factors compared between the two stocks.

How does Abbott Laboratories compare to Tesla?

Tesla (NASDAQ:TSLA) and Abbott Laboratories (NYSE:ABT) are related large-cap companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, valuation, media sentiment, analyst recommendations, dividends, risk and institutional ownership.

In the previous week, Tesla had 171 more articles in the media than Abbott Laboratories. MarketBeat recorded 214 mentions for Tesla and 43 mentions for Abbott Laboratories. Abbott Laboratories' average media sentiment score of 1.40 beat Tesla's score of 0.53 indicating that Abbott Laboratories is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tesla	89 Very Positive mention(s)	36 Positive mention(s)	49 Neutral mention(s)	28 Negative mention(s)	11 Very Negative mention(s)	Positive
Abbott Laboratories	36 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Tesla presently has a consensus price target of $401.74, indicating a potential upside of 14.42%. Abbott Laboratories has a consensus price target of $118.67, indicating a potential upside of 3.64%. Given Tesla's higher possible upside, equities research analysts clearly believe Tesla is more favorable than Abbott Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tesla	4 Sell rating(s)	19 Hold rating(s)	22 Buy rating(s)	1 Strong Buy rating(s)	2.43
Abbott Laboratories	0 Sell rating(s)	4 Hold rating(s)	20 Buy rating(s)	3 Strong Buy rating(s)	2.96

66.2% of Tesla shares are held by institutional investors. Comparatively, 75.2% of Abbott Laboratories shares are held by institutional investors. 19.9% of Tesla shares are held by company insiders. Comparatively, 0.5% of Abbott Laboratories shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Tesla has a beta of 1.83, indicating that its share price is 83% more volatile than the broader market. Comparatively, Abbott Laboratories has a beta of 0.59, indicating that its share price is 41% less volatile than the broader market.

Abbott Laboratories has a net margin of 11.65% compared to Tesla's net margin of 3.67%. Abbott Laboratories' return on equity of 17.69% beat Tesla's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tesla	3.67%	3.82%	2.27%
Abbott Laboratories	11.65%	17.69%	9.44%

Abbott Laboratories has lower revenue, but higher earnings than Tesla. Abbott Laboratories is trading at a lower price-to-earnings ratio than Tesla, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tesla	$94.83B	14.62	$3.79B	$1.08	325.11
Abbott Laboratories	$44.33B	4.47	$6.52B	$3.09	37.06

Summary

Abbott Laboratories beats Tesla on 9 of the 17 factors compared between the two stocks.

How does Abbott Laboratories compare to AbbVie?

AbbVie (NYSE:ABBV) and Abbott Laboratories (NYSE:ABT) are both large-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, media sentiment, risk, valuation, institutional ownership, earnings, analyst recommendations and profitability.

70.2% of AbbVie shares are held by institutional investors. Comparatively, 75.2% of Abbott Laboratories shares are held by institutional investors. 0.1% of AbbVie shares are held by insiders. Comparatively, 0.5% of Abbott Laboratories shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

AbbVie presently has a consensus price target of $275.73, suggesting a potential upside of 3.80%. Abbott Laboratories has a consensus price target of $118.67, suggesting a potential upside of 3.64%. Given AbbVie's higher possible upside, equities research analysts clearly believe AbbVie is more favorable than Abbott Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AbbVie	0 Sell rating(s)	5 Hold rating(s)	19 Buy rating(s)	2 Strong Buy rating(s)	2.88
Abbott Laboratories	0 Sell rating(s)	4 Hold rating(s)	20 Buy rating(s)	3 Strong Buy rating(s)	2.96

Abbott Laboratories has a net margin of 11.65% compared to AbbVie's net margin of 9.80%. Abbott Laboratories' return on equity of 17.69% beat AbbVie's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AbbVie	9.80%	-422.07%	14.34%
Abbott Laboratories	11.65%	17.69%	9.44%

Abbott Laboratories has lower revenue, but higher earnings than AbbVie. Abbott Laboratories is trading at a lower price-to-earnings ratio than AbbVie, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AbbVie	$64.39B	7.29	$4.23B	$3.54	75.04
Abbott Laboratories	$44.33B	4.47	$6.52B	$3.09	37.06

AbbVie pays an annual dividend of $6.92 per share and has a dividend yield of 2.6%. Abbott Laboratories pays an annual dividend of $2.52 per share and has a dividend yield of 2.2%. AbbVie pays out 195.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Abbott Laboratories pays out 81.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. AbbVie has increased its dividend for 53 consecutive years and Abbott Laboratories has increased its dividend for 54 consecutive years.

In the previous week, AbbVie had 6 more articles in the media than Abbott Laboratories. MarketBeat recorded 49 mentions for AbbVie and 43 mentions for Abbott Laboratories. Abbott Laboratories' average media sentiment score of 1.40 beat AbbVie's score of 1.13 indicating that Abbott Laboratories is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AbbVie	34 Very Positive mention(s)	5 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
Abbott Laboratories	36 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

AbbVie has a beta of 0.3, suggesting that its stock price is 70% less volatile than the broader market. Comparatively, Abbott Laboratories has a beta of 0.59, suggesting that its stock price is 41% less volatile than the broader market.

Summary

Abbott Laboratories beats AbbVie on 12 of the 20 factors compared between the two stocks.

How does Abbott Laboratories compare to Boston Scientific?

Boston Scientific (NYSE:BSX) and Abbott Laboratories (NYSE:ABT) are both large-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, dividends, institutional ownership, risk, media sentiment, earnings, profitability and analyst recommendations.

89.1% of Boston Scientific shares are held by institutional investors. Comparatively, 75.2% of Abbott Laboratories shares are held by institutional investors. 0.3% of Boston Scientific shares are held by company insiders. Comparatively, 0.5% of Abbott Laboratories shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Boston Scientific has a beta of 0.56, suggesting that its share price is 44% less volatile than the broader market. Comparatively, Abbott Laboratories has a beta of 0.59, suggesting that its share price is 41% less volatile than the broader market.

Boston Scientific has a net margin of 17.50% compared to Abbott Laboratories' net margin of 11.65%. Boston Scientific's return on equity of 19.28% beat Abbott Laboratories' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Boston Scientific	17.50%	19.28%	10.89%
Abbott Laboratories	11.65%	17.69%	9.44%

Boston Scientific currently has a consensus target price of $71.62, suggesting a potential upside of 37.66%. Abbott Laboratories has a consensus target price of $118.67, suggesting a potential upside of 3.64%. Given Boston Scientific's higher probable upside, analysts plainly believe Boston Scientific is more favorable than Abbott Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Boston Scientific	2 Sell rating(s)	5 Hold rating(s)	24 Buy rating(s)	0 Strong Buy rating(s)	2.71
Abbott Laboratories	0 Sell rating(s)	4 Hold rating(s)	20 Buy rating(s)	3 Strong Buy rating(s)	2.96

In the previous week, Abbott Laboratories had 2 more articles in the media than Boston Scientific. MarketBeat recorded 43 mentions for Abbott Laboratories and 41 mentions for Boston Scientific. Boston Scientific's average media sentiment score of 1.44 beat Abbott Laboratories' score of 1.40 indicating that Boston Scientific is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Boston Scientific	36 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Abbott Laboratories	36 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Abbott Laboratories has higher revenue and earnings than Boston Scientific. Boston Scientific is trading at a lower price-to-earnings ratio than Abbott Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Boston Scientific	$21.00B	3.59	$2.90B	$2.47	21.06
Abbott Laboratories	$44.33B	4.47	$6.52B	$3.09	37.06

Summary

Abbott Laboratories beats Boston Scientific on 10 of the 17 factors compared between the two stocks.

Get Abbott Laboratories News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ABT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ABT vs. The Competition

Export

Metric	Abbott Laboratories	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$194.98B	$5.91B	$7.18B	$24.19B
Dividend Yield	2.24%	1.76%	2.55%	3.73%
P/E Ratio	37.06	26.18	268.94	30.14
Price / Sales	4.47	41.28	618.72	19.90
Price / Cash	16.12	33.29	78.23	31.97
Price / Book	3.83	6.06	13.28	6.84
Net Income	$6.52B	$149.38M	$3.47B	$1.07B
7 Day Performance	2.81%	1.58%	2.21%	-0.57%
1 Month Performance	12.56%	6.59%	5.29%	2.97%
1 Year Performance	-13.45%	10.17%	29.17%	18.26%

Abbott Laboratories Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ABT Abbott Laboratories	4.6035 of 5 stars	$114.77 +0.3%	$118.67 +3.4%	-12.7%	$198.88B	$44.33B	37.19	115,000	Positive News
DXCM DexCom	4.3312 of 5 stars	$87.65 +3.4%	$88.71 +1.2%	+11.1%	$31.98B	$4.66B	34.64	11,000
ISRG Intuitive Surgical	4.5008 of 5 stars	$393.38 +3.8%	$509.02 +29.4%	-17.0%	$133.83B	$10.06B	45.06	17,021
TSLA Tesla	4.0859 of 5 stars	$330.88 +0.7%	$401.74 +21.4%	+6.6%	$1.30T	$94.83B	306.37	134,785	Trending News Analyst Forecast
ABBV AbbVie	4.8111 of 5 stars	$247.86 +0.7%	$275.70 +11.2%	+29.0%	$434.70B	$61.16B	70.02	57,000	Positive News Analyst Forecast Insider Trade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:ABT) was last updated on 8/20/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Abbott Laboratories (ABT) Competitors

ABT vs. DXCM, ISRG, TSLA, ABBV, and BSX

How does Abbott Laboratories compare to DexCom?

Summary

How does Abbott Laboratories compare to Intuitive Surgical?

Summary

How does Abbott Laboratories compare to Tesla?

Summary

How does Abbott Laboratories compare to AbbVie?

Summary

How does Abbott Laboratories compare to Boston Scientific?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ABT vs. The Competition

Abbott Laboratories Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Abbott Laboratories (ABT) Competitors

ABT vs. DXCM, ISRG, TSLA, ABBV, and BSX

How does Abbott Laboratories compare to DexCom?

Which has higher valuation & earnings, ABT or DXCM?

Is ABT or DXCM more profitable?

Do analysts recommend ABT or DXCM?

Do insiders and institutionals believe in ABT or DXCM?

Which has more volatility and risk, ABT or DXCM?

Does the media prefer ABT or DXCM?

Summary

How does Abbott Laboratories compare to Intuitive Surgical?

Which has more risk & volatility, ISRG or ABT?

Do analysts prefer ISRG or ABT?

Is ISRG or ABT more profitable?

Which has better earnings and valuation, ISRG or ABT?

Does the media refer more to ISRG or ABT?

Do insiders & institutionals hold more shares of ISRG or ABT?

Summary

How does Abbott Laboratories compare to Tesla?

Does the media favor TSLA or ABT?

Do analysts rate TSLA or ABT?

Do insiders and institutionals have more ownership in TSLA or ABT?

Which has more risk & volatility, TSLA or ABT?

Is TSLA or ABT more profitable?

Which has higher valuation and earnings, TSLA or ABT?

Summary

How does Abbott Laboratories compare to AbbVie?

Do institutionals and insiders believe in ABBV or ABT?

Do analysts prefer ABBV or ABT?

Is ABBV or ABT more profitable?

Which has stronger valuation & earnings, ABBV or ABT?

Is ABBV or ABT a better dividend stock?

Does the media favor ABBV or ABT?

Which has more risk & volatility, ABBV or ABT?

Summary

How does Abbott Laboratories compare to Boston Scientific?

Do insiders & institutionals believe in BSX or ABT?

Which has more volatility and risk, BSX or ABT?

Is BSX or ABT more profitable?

Do analysts rate BSX or ABT?

Does the media prefer BSX or ABT?

Which has higher valuation and earnings, BSX or ABT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ABT vs. The Competition

Abbott Laboratories Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools